FFH-18751-26414
4 vaccinations
11 coded responses
39 check-ins
10 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 220 / VA
- Registered
- 2021-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-23
Registered in v-safe
-
2021-01-23
Dose 1 — Pfizer-BioNTech
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
-
2021-01-27
Survey response — days 1–6 daily, dose 1MedDRA: Migraine, Pre-existing disease — Feeling: GoodFree text: Migraine (pre-existing condition)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-28
- 2021-01-29
-
2021-02-13
Dose 2 — Pfizer-BioNTech
-
2021-02-15
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Day 2 after 2d Pfizer vaccine. Day 1 with minimal symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: Photophobia — Feeling: Fair · Site: Redness · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Eyes are light sensitive; its hard to readMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-20
-
2021-03-27
Survey response — day 42, dose 2MedDRA: Rash — Feeling: GoodFree text: New rash around left eyeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-15
Survey response — 3 months, dose 2MedDRA: Eczema eyelids, Rash, Self-medication, Skin discolouration, Skin exfoliation — Feeling: GoodFree text: Two months ago, I developed white, scaly, eczema-like patches above and below left eye. Hasnt spread, doesnt respond to OTC remedies. Will see PCP next monthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-14
Dose 3 — Pfizer-BioNTech
-
2021-08-14
Survey response — 6 months, dose 2MedDRA: Dermatitis psoriasiform, Erythema, Pre-existing disease, Skin discolouration, Skin exfoliation — Feeling: GoodFree text: I developed a psoriatic rash after 2d Pfizer dose (reddened skin, white flaking, streaking above and below left eye) that eventually disappeared about a month ago. I have RA and just got Pfizer#3. How can I inform you if symptoms recur?MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-01
- 2021-11-13
-
2022-02-12
Dose 4 — Pfizer-BioNTech
- 2022-02-12
- 2022-02-12
-
2022-02-13
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-02-14
- 2022-02-15
- 2022-02-16
- 2022-02-17
- 2022-02-18
-
2022-02-21
Survey response — day 7, dose 4MedDRA: Abdominal discomfort — Feeling: Fair · Nausea, DiarrheaFree text: Upset stomachMedDRA releases: 2024-11 · check-in free text available
-
2022-02-28
Survey response — day 14, dose 4MedDRA: Alanine aminotransferase increased, Aspartate aminotransferase increased — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: ALT & AST liver tests elevated for first time in 15 yearsMedDRA releases: 2024-11 · check-in free text available
-
2022-02-28
Report sent to call center — day 14, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-04
- 2022-03-08
-
2022-03-08
Call successfulParticipant prefers to complete VAERS report online
- 2022-03-14
- 2022-03-19
-
2022-03-28
Survey response — day 42, dose 4MedDRA: Alanine aminotransferase increased, Aspartate aminotransferase increased, Office visit, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: 2weeks after booster, blood tests for liver function ALT & AST we're elevated. Rheumatologist temporarily stopped a medication for 3 weeks (2doses). Retest back to normal. Dr stated she'd seen this reactionMedDRA releases: 2024-11 · check-in free text available
-
2022-03-28
Report sent to call center — day 42, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-03-30
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-05-14
-
2022-08-13
Survey response — 6 months, dose 4MedDRA: COVID-19, Decreased appetite, Fatigue, Headache, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Developed COVID-19 (positive tests) on 7/3/22 after returning via plane from France. BAD Headache, sore throat, fatigue, no appetite, runny nose x 3-4 days. Continued to test positive for 11 days.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-13
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-15
- 2022-08-15
- 2022-08-15
-
2023-02-12
Survey response — 12 months, dose 4MedDRA: Rash, Urticaria — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-12
Report sent to call center — 12 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-02-13
Call successfulDoes not wish to fill out VAERS report
-
2023-02-13
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Pfizer-BioNTech | |
| 2 | 2021-02-13 | Pfizer-BioNTech | |
| 3 | 2021-08-14 | Pfizer-BioNTech | No |
| 4 | 2022-02-12 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 successful
1 wait over 3 months for a first call
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Migraine (pre-existing condition)
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Day 2 after 2d Pfizer vaccine. Day 1 with minimal symptoms
Systemic reaction (other): Eyes are light sensitive; its hard to read
Release 6 — day 42, dose 2
Symptoms: New rash around left eye
Release 8 — 3 months, dose 2
Symptoms: Two months ago, I developed white, scaly, eczema-like patches above and below left eye. Hasnt spread, doesnt respond to OTC remedies. Will see PCP next month
Release 9 — 6 months, dose 2
Symptoms: I developed a psoriatic rash after 2d Pfizer dose (reddened skin, white flaking, streaking above and below left eye) that eventually disappeared about a month ago. I have RA and just got Pfizer#3. How can I inform you if symptoms recur?
Release 11 — day 7, dose 4
Systemic reaction (other): Upset stomach
Release 11 — day 14, dose 4
Symptoms: ALT & AST liver tests elevated for first time in 15 years
Release 11 — day 42, dose 4
Symptoms: 2weeks after booster, blood tests for liver function ALT & AST we're elevated. Rheumatologist temporarily stopped a medication for 3 weeks (2doses). Retest back to normal. Dr stated she'd seen this reaction
Release 12 — 6 months, dose 4
Symptoms: Developed COVID-19 (positive tests) on 7/3/22 after returning via plane from France. BAD Headache, sore throat, fatigue, no appetite, runny nose x 3-4 days. Continued to test positive for 11 days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Alanine aminotransferase increased | · | · | ✓ |
| SD | Aspartate aminotransferase increased | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Dermatitis psoriasiform | ✓ | · | ✓ |
| SD | Eczema eyelids | · | · | ✓ |
| SD | Erythema | ✓ | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SD | Skin discolouration | ✓ | · | ✓ |
| SD | Skin exfoliation | ✓ | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SRO | Abdominal discomfort | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
| SRO | Photophobia | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release